ArticleChinese medicine2025

Atractylenolide I ameliorated the growth and enzalutamide resistance of castration-resistant prostate cancer by targeting KIF15.

Chenglin Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.